title: Comparative proteome, transcriptome, and genome analysis of a gonadal and an extragonadal germ cell tumor cell line.
abstract: Whereas clinical differences between testicular and extragonadal germ cell tumors (GCT), like reduced cisplatin sensitivity of extragonadal tumors, are well-established, little is known about underlying tumor biology. A combined approach using global proteome analysis and RT-PCR to assess mRNA levels of selected proteins on the one hand, and array comparative genomic hybridization (array-CGH), on the other hand, was used to compare two germ cell tumor (GCT) cell lines showing embryonal carcinoma histology, one of testicular, and one of extragonadal origin. Overall, the two cell lines show remarkably similar protein profiles. In total, 66 proteins were found to be differentially expressed in an at least 2-fold manner. Of these, 35 proteins (53%) could be positively identified by peptide mass fingerprinting and database search. mRNA levels of 27 differentially expressed proteins were analyzed by RT-PCR. In 17/27 genes (63%), differences in mRNA expression corresponded with differences detected on protein level, suggesting that these proteins are mainly regulated through transcription. Interestingly, no close correlation was found between proteomic and genomic analysis: 13/30 genes (43%) with higher protein levels in one cell line showed higher copy numbers of the respective gene loci in array-CGH analysis. Corresponding differences from proteome, transcriptome, and mRNA analyses were found in 9 of 27 proteins (33%). Several proteins potentially involved in cisplatin resistance were identified in the extragonadal cell line, suggesting that the cisplatin-resistant phenotype of this cell line is multifactorial. Furthermore, our data demonstrate that a combined approach of proteome, transcriptome, and genome analysis is a promising tool to gain information on gene regulation in human tumors.
authors.affiliation: Department of Oncology/Hematology/Bone Marrow Transplantation with the section of Pneumology, University Hospital Hamburg Eppendorf, Germany.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Glaesener
authors.forename: Friedemann
authors.initials: F
authors.lastname: Honecker
authors.forename: Imke M
authors.initials: IM
authors.lastname: Veltman
authors.forename: Ad J M
authors.initials: AJ
authors.lastname: Gillis
authors.forename: Tina
authors.initials: T
authors.lastname: Rohlfing
authors.forename: Thomas
authors.initials: T
authors.lastname: Streichert
authors.forename: Benjamin
authors.initials: B
authors.lastname: Otto
authors.forename: Tim H
authors.initials: TH
authors.lastname: Brummendorf
authors.forename: Leendert H J
authors.initials: LH
authors.lastname: Looijenga
authors.forename: Carsten
authors.initials: C
authors.lastname: Bokemeyer
authors.forename: Stefan
authors.initials: S
authors.lastname: Balabanov
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology; D045744:Cell Line, Tumor; D002945:Cisplatin / Q000494:pharmacology; D015180:Electrophoresis, Gel, Two-Dimensional; D016678:Genome; D006801:Humans; D009373:Neoplasms, Germ Cell and Embryonal / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D020543:Proteome; D012333:RNA, Messenger / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D000970:Antineoplastic Agents; D020543:Proteome; D012333:RNA, Messenger; D002945:Cisplatin